NovaBay Pharmaceuticals Quick Ratio 2007-2019 | NBY

Historical quick ratio values for NovaBay Pharmaceuticals (NBY) over the last 10 years.
NovaBay Pharmaceuticals Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-09-30 $0.01B $0.01B 1.87
2019-06-30 $0.01B $0.00B 2.04
2019-03-31 $0.01B $0.01B 1.26
2018-12-31 $0.01B $0.00B 2.17
2018-09-30 $0.01B $0.00B 2.71
2018-06-30 $0.01B $0.00B 3.42
2018-03-31 $0.01B $0.00B 3.83
2017-12-31 $0.01B $0.01B 1.71
2017-09-30 $0.01B $0.01B 1.78
2017-06-30 $0.01B $0.01B 2.17
2017-03-31 $0.01B $0.00B 2.50
2016-12-31 $0.01B $0.00B 3.15
2016-09-30 $0.01B $0.00B 3.58
2016-06-30 $0.01B $0.00B 1.25
2016-03-31 $0.00B $0.00B 0.83
2015-12-31 $0.00B $0.01B 0.69
2015-09-30 $0.01B $0.00B 1.08
2015-06-30 $0.01B $0.00B 2.97
2015-03-31 $0.01B $0.00B 1.92
2014-12-31 $0.01B $0.00B 1.92
2014-09-30 $0.01B $0.00B 4.26
2014-06-30 $0.01B $0.00B 6.28
2014-03-31 $0.02B $0.00B 7.11
2013-12-31 $0.02B $0.00B 4.06
2013-09-30 $0.01B $0.00B 3.73
2013-06-30 $0.01B $0.00B 4.28
2013-03-31 $0.01B $0.00B 5.85
2012-12-31 $0.02B $0.00B 5.75
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.00
2011-06-30 $0.00B $0.00B 0.00
2011-03-31 $0.00B $0.00B 0.00
2010-12-31 $0.00B $0.00B 0.00
2010-09-30 $0.00B $0.00B 0.00
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.01B 0.00
2009-06-30 $0.00B $0.01B 0.00
2009-03-31 $0.00B $0.01B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.00B $0.01B 0.00
2008-06-30 $0.00B $0.01B 0.00
2008-03-31 $0.00B $0.01B 0.00
2007-12-31 $0.00B $0.01B 0.00
2007-09-30 $0.00B $0.01B 0.00
2007-06-30 $0.00B 0.00
2007-03-31 $0.00B 0.00
2006-09-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.017B $0.013B
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.550B 39.07
Takeda Pharmaceutical (TAK) Japan $58.571B 10.38
Astellas Pharma (ALPMY) Japan $32.091B 16.03
Eisai (ESALY) Japan $22.967B 44.28
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $17.622B 23.09
Merck (MKGAF) Germany $17.318B 23.63
Neurocrine Biosciences (NBIX) United States $9.609B 266.97
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.636B 35.53
Ionis Pharmaceuticals (IONS) United States $8.509B 17.23
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.627B 9.74
IPSEN SA ADR (IPSEY) France $6.090B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.178B 15.75
United Therapeutics (UTHR) United States $4.694B 0.00
Nektar Therapeutics (NKTR) United States $4.139B 0.00
Evotec AG (EVTCY) Germany $4.138B 66.78
FibroGen (FGEN) United States $3.968B 116.61
Arrowhead Pharmaceuticals (ARWR) United States $3.913B 72.62
Sage Therapeutics (SAGE) United States $3.603B 0.00
PTC Therapeutics (PTCT) United States $3.524B 0.00
ChemoCentryx (CCXI) United States $2.837B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.802B 11.34
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.277B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.024B 55.74
Xencor (XNCR) United States $1.995B 60.64
Tilray (TLRY) Canada $1.947B 0.00
Heron Therapeutics (HRTX) United States $1.932B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.840B 22.36
Corcept Therapeutics (CORT) United States $1.553B 17.42
USANA Health Sciences (USNA) United States $1.525B 15.94
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.391B 9.49
Endo (ENDP) Ireland $1.377B 2.53
Zogenix (ZGNX) United States $1.335B 0.00
Akebia Therapeutics (AKBA) United States $1.207B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.060B 32.84
Portola Pharmaceuticals (PTLA) United States $1.051B 0.00
Karyopharm Therapeutics (KPTI) United States $1.010B 0.00
Aerie Pharmaceuticals (AERI) United States $1.000B 0.00
Radius Health (RDUS) United States $0.894B 0.00
ImmunoGen (IMGN) United States $0.810B 0.00
Collegium Pharmaceutical (COLL) United States $0.802B 0.00
Flexion Therapeutics (FLXN) United States $0.661B 0.00
Molecular Templates (MTEM) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.571B 0.00
TherapeuticsMD (TXMD) United States $0.559B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.537B 65.13
Ardelyx (ARDX) United States $0.528B 0.00
Translate Bio (TBIO) United States $0.474B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 20.27
Organogenesis Holdings (ORGO) United States $0.458B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.419B 0.00
DURECT (DRRX) United States $0.417B 0.00
Calithera Biosciences (CALA) United States $0.402B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.386B 0.00
Recro Pharma (REPH) United States $0.384B 0.00
Siga Technologies (SIGA) United States $0.383B 8.76
BioCryst Pharmaceuticals (BCRX) United States $0.378B 0.00
Harpoon Therapeutics (HARP) United States $0.377B 0.00
Lannett Co Inc (LCI) United States $0.369B 5.94
Indivior (INVVY) United States $0.356B 2.11
Corbus Pharmaceuticals Holdings (CRBP) United States $0.355B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.352B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.343B 0.00
Rafael Holdings (RFL) United States $0.333B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.327B 0.00
OptiNose (OPTN) United States $0.310B 0.00
Ocular Therapeutix (OCUL) United States $0.272B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.269B 0.00
MEI Pharma (MEIP) United States $0.251B 0.00
KalVista Pharmaceuticals (KALV) United States $0.249B 0.00
IMV INC (IMV) Canada $0.238B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.221B 0.00
Nature's Sunshine Products (NATR) United States $0.199B 34.30
Taiwan Liposome (TLC) Taiwan $0.195B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 2.35
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.123B 0.00
Xeris Pharmaceuticals (XERS) United States $0.118B 0.00
CannTrust Holdings (CTST) Canada $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Otonomy (OTIC) United States $0.109B 0.00
Redhill Biopharma (RDHL) Israel $0.107B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.106B 0.00
Aquestive Therapeutics (AQST) United States $0.106B 0.00
CV Sciences (CVSI) United States $0.087B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.45
Entasis Therapeutics Holdings (ETTX) United States $0.068B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.064B 0.00
Nivalis Therapeutics (ALPN) United States $0.060B 0.00
Aclaris Therapeutics (ACRS) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.051B 23.03
Forward Pharma (FWP) Denmark $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Vical (BBI) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Novan (NOVN) United States $0.015B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00